Financial news, markets, and business updates
Proposed Medicare fee schedule changes may incentivize doctors to provide more support for smoking cessation, increasing reimbursements for counseling services.
GSK has ceased its efforts to develop a chronic cough therapy, citing the challenges faced during clinical trials.
Sonothera's ultrasound technology promises treatments for Duchenne muscular dystrophy, but experts remain skeptical amid a lack of clinical data.
Advocates worry that excluding trans youth in some way from LGBTQ+ counseling services provided through the 988 crisis line could be harmful.
MAHA's recent initiatives signal a pivotal shift in the dialogue around mental health care, emphasizing deprescribing while sidelining concrete solutions.
The FTC's settlement with CVS Caremark aims to save Americans up to $8.5 billion on insulin by overhauling price manipulation and rebate practices.
Cyclospora infections are at a record high, with Michigan officials pointing to lettuce as a potential source amid an outbreak across multiple states.
The ex-Akero Therapeutics team has formed Avere Therapeutics, targeting immunology with an oral IL-23 inhibitor from a Chinese source.
Dr. Jeremy Faust, a Boston emergency physician, uses his platform to blend urgent medical insights with broader health discussions, attracting a large audience.
The sharp rise in ACA marketplace premium costs significantly affects small businesses, raising new challenges in employee health benefits.
A father invests $70 million into developing a gene therapy for his daughter’s rare condition, seeking breakthroughs for patients like her.
The search for the next FDA commissioner heats up with notable contenders, while AstraZeneca's heart drug faces a major trial setback.
Recent studies suggest that psilocybin therapy may offer enduring relief for patients with depression, presenting a significant advancement in treatment options.
The decline of employer-based health insurance is straining workers and businesses, raising serious concerns about its sustainability.
Vertex Pharmaceuticals is set to acquire Crinetics Pharmaceuticals for $10 billion, marking a pivotal expansion into rare disease treatments.
Soaring health insurance expenses are pushing small businesses to abandon employee health coverage, challenging America's employer-based system.
With rising expenses, small companies are increasingly unable to provide health insurance, impacting millions of American workers and their families.
The current Ebola outbreak in the DRC faces severe obstacles to containment, risking a permanent endemic situation that could have global repercussions.
Medicare plans to reduce payments for 340B drugs by over 33%, a move criticized for potentially harming safety-net hospitals while benefiting for-profits.
A recent court ruling benefits Amgen, blocking a price cap on Enbrel, while Medicare expands access to obesity medications for older Americans.